COMP <GO>
OTIS vs NVDA // EV/EBITDA & P/E VALUATION
Otis Worldwide Corporation (NYSE) VS. NVIDIA Corporation (NASDAQ) • 15-METRIC TALLY: OTIS 6
— NVDA 7
▲ EV/EBITDA & P/E VALUATION LEADER: OTIS
LAST: $75.75 (+1.53%) • MKT CAP: $28.40B
valuation
12.7x
LAST: $204.64 (-4.22%) • MKT CAP: $5.15T
valuation
23.2x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OTIS VS. NVDA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | OTIS | NVDA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 74.67% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 74.20% | 65.06% | +9.14 | OTIS | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 12.7x | 23.2x | -10.51 | OTIS | /valuation <GO> |
| Free Cash Flow Yield | 3.33% | 2.58% | +0.75 | OTIS | /fcf-yield <GO> |
| Operating Margin | 14.80% | 65.21% | -50.41 | NVDA | /operating-margins <GO> |
| Net Profit Margin | 9.60% | 63.66% | -54.06 | NVDA | /net-margins <GO> |
| Revenue Growth (YoY) | 1.20% | 83.38% | -82.18 | NVDA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.28% | 0.02% | +2.26 | OTIS | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.90 | 19.52 | -16.62 | NVDA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 4/9 | +2.00 | OTIS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 9.01% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 62.2 | 51.1 | +11.10 | OTIS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.13 | 2.04 | -0.91 | NVDA | /macro-sensitivity <GO> |
| Forward P/E Multiple | 19.1x | 14.5x | +4.63 | NVDA | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $28.40B | $5.15T | -$5.12T | NVDA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | OTIS REV | NVDA REV | OTIS GROSS % | NVDA GROSS % | OTIS FCF | NVDA FCF |
|---|---|---|---|---|---|---|
| FY 2026 | — | $215.94B | — | 71.1% | — | $96.68B |
| FY 2025 | $14.43B | $130.50B | — | 75.0% | $946.6M | $60.85B |
| FY 2024 | $14.26B | $60.92B | — | 72.7% | $921.3M | $27.02B |
| FY 2023 | $14.21B | $26.97B | — | 56.9% | $987.6M | $3.81B |
| FY 2022 | — | $26.91B | — | 64.9% | — | $8.13B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OTIS // BETA 1.13
NVDA // BETA 2.04